Mia's Feed
Medical News & Research

AI Innovation Enables Detection of Fatty Liver Disease via Chest X-Rays

AI Innovation Enables Detection of Fatty Liver Disease via Chest X-Rays

Share this article

Innovative AI model analyzes routine chest X-rays to detect fatty liver disease, offering a cost-effective and accessible diagnostic method that could transform early screening strategies.

2 min read

Recent advancements in artificial intelligence (AI) have paved the way for new, more accessible methods to diagnose fatty liver disease, a condition affecting approximately one in four individuals globally. Traditionally, identifying fatty liver requires specialized imaging tests such as ultrasounds, CT scans, or MRIs, which can be costly and less readily available. However, researchers from Osaka Metropolitan University have developed an innovative AI model that leverages routine chest X-ray images to detect this condition.

While chest X-rays are primarily used to evaluate the lungs and heart, they also inadvertently capture parts of the liver. This serendipitous overlap allows for deep learning models to analyze these images for signs of fatty liver disease. A study involving 6,599 X-ray images from 4,414 patients utilized controlled attenuation parameter (CAP) scores to train the AI. The model demonstrated high accuracy, with an area under the receiver operating characteristic curve (AUC) between 0.82 and 0.83, indicating strong diagnostic potential.

The integration of AI with commonly performed and affordable chest X-rays could significantly improve early detection of fatty liver disease. Professor Sawako Uchida-Kobayashi highlighted the potential impact, stating that developing such diagnostic methods using readily available imaging could enhance screening efforts and facilitate timely treatment.

This breakthrough was detailed in the journal Radiology: Cardiothoracic Imaging and represents a promising step toward more efficient and cost-effective liver disease diagnostics. As research progresses, this approach could become a routine part of medical assessments, enabling broader screening and better patient outcomes.

Source: https://medicalxpress.com/news/2025-06-ai-fatty-liver-disease-chest.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New Insights into How Placebo Effects Differ Across Body Regions

New research uncovers how placebo-induced pain relief is organized in the brainstem, varying by body region, opening doors for targeted pain treatments beyond opioids.

Understanding Nutrient Transport in the Body: Insights into Cancer Treatment

Discover how mapping nutrient transport pathways in the body opens new possibilities for cancer therapy and disease management, highlighting recent breakthroughs in cellular transporter research.

The Impact of Internet Bots on Scientific Research Integrity

The rise of sophisticated internet bots and AI technologies presents significant challenges to maintaining integrity in online scientific research, risking data validity and trust.

The Impact of TRIO Gene Variants on Neurodevelopmental Disorders

Recent research uncovers how variants in the TRIO gene influence brain development and contribute to neurodevelopmental disorders like autism and schizophrenia, offering new avenues for targeted therapies.